Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-Persistent pollutants affect programmed cell death

Critical Reviews in Toxicology

Volumn 41, Issue 4, 2011, Pages 292-320

  Chopra, Martin ^a   Schrenk, Dieter ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Apoptosis; aryl hydrocarbon receptor; carcinogenesis; cell death; immune suppression; TCDD; thymic atrophy; tumor promotion

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; AROMATIC HYDROCARBON RECEPTOR; BLEOMYCIN; CGP 77675; CYCLOHEXIMIDE; DIETHYLNITROSAMINE; DIOXIN; EPIDERMAL GROWTH FACTOR; ETOPOSIDE; HYDROGEN PEROXIDE; IONOMYCIN; LEPTOMYCIN B; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N (2 FLUORENYL)ACETAMIDE; OCHRATOXIN; PARAQUAT; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN; PROTEIN BAX; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; STAUROSPORINE; TACROLIMUS; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE TOXICITY; APOPTOSIS; BREAST EPITHELIUM; CARCINOGENICITY; CELL ACTIVATION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CHRONIC TOXICITY; CYTOTOXICITY; DENDRITIC CELL; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INHIBITION; DRUG METABOLISM; EMBRYONAL TISSUE; ERYTHROCYTE; FETUS CELL; GENE EXPRESSION; GENOTOXICITY; GROWTH INHIBITION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; LIVER; LIVER CELL; LIVER TOXICITY; LYMPHOMA CELL LINE; MYOBLAST; NERVE CELL; NICK END LABELING; NONHUMAN; PANCREAS; POLLUTANT; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SKIN; T LYMPHOCYTE; THYMOCYTE; ULTRAVIOLET C RADIATION; XENOBIOTIC METABOLISM;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; DIOXINS; ENVIRONMENTAL POLLUTANTS; HUMANS; LIVER; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 79953131106     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2010.524635     Document Type: Review

References (233)

1. Ahmed S, Shibazaki M, Takeuchi T, Kikuchi H. (2005). Protein kinase Cθ activity is involved in the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced signal transduction pathway leading to apoptosis in L-MAT, a human lymphoblastic T-cell line. FEBS J 272:903-915. (Pubitemid 40278829)
2. Al-Anati L, Högberg J, Stenius U. (2009). Non-dioxin-like-PCBs phosphorylate Mdm2 at Ser166 and attenuate the p53 response in HepG2 cells. Chem Biol Interact 182:191-198.
3. Altman A, Villalba M. (2002). Protein kinase Cθ (PKCθ): A key enzyme in T cell life and death. J Biochem 132:841-846. (Pubitemid 36090648)
4. Ambolet-Camoit A, Bui LC, Pierre S, Chevallier A, Marchand A, Coumoul X, Garlatti M, Andreau K, Barouki R, Aggerbeck M. (2010). 2,3,7,8- Tetrachlorodibenzo-p-dioxin counteracts the p53 response to a genotoxicant by up-regulating expression of the metastasis marker AGR2 in the hepatocarcinoma cell line HepG2. Toxicol Sci 15:501-512.
5. Ashkenazi A. (2008). Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 19:325-331.
6. Ashkenazi A, Dixit VM. (1998). Death receptors: Signaling and modulation. Science 281:1305-1308. (Pubitemid 28406815)
7. Aylward LL, Brunet RC, Carrier G, Hays SM, Cushing CA, Needham LL, Patterson DG Jr, Gerthoux PM, Brambilla P, Mocarelli P. (2005). Concentration-dependent TCDD elimination kinetics in humans: Toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J Expo Anal Environ Epidemiol 15:51-65. (Pubitemid 40170984)
8. Bach LA. (2005). IGFBP-6 fve years on; not so 'forgotten′? Growth Horm IGF Res 15:185-192. (Pubitemid 40754120)
9. Bankoti J, Burnett A, Navarro S, Miller AK, Rase B, Shepherd DM. (2010). Efects of TCDD on the fate of naive dendritic cells. Toxicol Sci 115:422-434.
10. Biswas G, Srinivasan S, Anandatheerthavarada HK, Avadhani NG. (2008). Dioxin-mediated tumor progression through activation of mitochondria-to-nucleus stress signaling. Proc Natl Acad Sci USA 105:186-191.
11. Beischlag T V, Morales JL, Hollingshead BD, Perdew GH. (2008). Te aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 18:207-250. (Pubitemid 351620286)
12. Besteman EG, Zimmerman KL, Holladay SD. (2005). Tetrachlorodibenzo-p- dioxin (TCDD) inhibits diferentiation and increases apoptotic cell death of precursor T cells in the fetal mouse thymus. J Immunotoxicol 2:1-8.
13. Besteman EG, Zimmerman KL, Huckle WR, Prater MR, Gogal RM Jr, Holladay SD. (2007). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) or diethylstilbestrol (DES) cause similar hematopoietic hypocellularity and hepatocellular changes in murine fetal liver, but diferentially afect gene expression. Toxicol Pathol 35:786-792. (Pubitemid 47613612)
14. Bock KW, Köhle C. (2009). Te mammalian aryl hydrocarbon (Ah) receptor: From mediator of dioxin toxicity toward physiological function in skin and liver. Biol Chem 390:1225-1235.
15. Bohnenberger S, Wagner B, Schmitz H-J, Schrenk D. (2001). Inhibition of apoptosis in rat hepatocytes treated with 'non-dioxin-like′ polychlorinated biphenyls. Carcinogenesis 22:1601-1606. (Pubitemid 32952137)
16. Boverhof DR, Burgoon LD, Tashiro C, Sharratt B, Chittim B, Harkema JR, Mendrick DL, Zacharewski TR. (2006). Comparative toxicogenomic analysis of the hepatotoxic efects of TCDD in Spraque Dawley rats and C57BL/6 mice. Toxicol Sci 94:398-416. (Pubitemid 44817156)
17. Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS. (1999). p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem 274:15237-15244.
18. Camacho IA, Hassuneh MR, Nagarkatti M, Nagarkatti PS. (2001). Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD)-induced immunotoxicity in peripheral T cells. Toxicology 165:51-63. (Pubitemid 32718697)
19. Camacho IA, Nagarkatti M, Nagarkatti PS. (2002). 2,3,7,8- Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells. Arch Toxicol 76:570-580.
20. Camacho IA, Nagarkatti M, Nagarkatti PS. (2004). Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 78:96-106. (Pubitemid 38351428)
21. Camacho IA, Singh N, Hegde VL, Nagarkatti M, Nagarkatti PS. (2005). Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-κB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells. J Immunol 175:90-103. (Pubitemid 40884305)
22. Cantrell SM, Joy-Schlezinger J, Stegeman JJ, Tillitt DE, Hannink M. (1997). Correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced apoptotic cell death in the embryonic vasculature with embryotoxicity. Toxicol Appl Pharmacol 148:24-34. (Pubitemid 28072772)
23. Carvajal-Gonzalez JM, Roman AC, Cerezo-Guisado MI, Rico-Leo EM, Martin-Partido G, Fernandez-Salguero PM. (2009). Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGFbeta. J Cell Sci 122:1823-1833.
24. Chen S-C, Liao T-L, Wei Y-H, Tzeng C-R, Kao S-H. (2010). Endocrine disruptor, dioxin (TCDD)-induced mitochondrial dysfunction and apoptosis in human trophoblast-like JAR cells. Mol Hum Reprod 16:361-372.
25. Chiaro CR, Morales JL, Prabhu KS, Perdew GH. (2008). Leukotriene A4 metabolites are endogenous ligands for the Ah receptor. Biochemistry 47:8445-8455.
26. Chiaro CR, Patel RD, Perdew GH. (2008). 12(R)-Hydroxy-5(Z),8(Z),10(E), 14(Z)-eicosatetraenoic acid [12(R)-HETE], an arachidonic acid derivative, is an activator of the aryl hydrocarbon receptor. Mol Pharmacol 74:1649-1656.
27. Choi EJ, Toscano DG, Ryan JA, Riedel N, Toscano WA Jr. (1991). Dioxin induces transforming growth factor-alpha in human keratinocytes. J Biol Chem 266:9591-9597. (Pubitemid 21906697)
28. Chopra M, Dharmarajan AM, Meiss G, Schrenk D. (2009). Inhibition of UV-C light-induced apoptosis in liver cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci 111:49-63.
29. Chopra M, Gährs M, Haben M, Michels C, Schrenk D. (2010). Inhibition of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin depends on protein biosynthesis. Cell Biol Toxicol 26:391-401.
30. Christensen JG, Gonzales AJ, Cattley RC, Goldsworthy TL. (1998). Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Difer 9:815-825. (Pubitemid 28425878)
31. Danial NN, Korsmeyer SJ. (2004). Cell death: Critical control points. Cell 116:205-219. (Pubitemid 38167313)
32. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241. (Pubitemid 27456390)
33. Davis JW II, Melendez K, Salas VM, Lauer FT, Burchiel SW. (2000). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits growth factor withdrawal-induced apoptosis in the human mammary epithelial cell line, MCF-10A. Carcinogenesis 21:881-886. (Pubitemid 30265129)
34. Davis JW II, Lauer FT, Burdick AD, Hudson LG, Burchiel SW. (2001). Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: Correlation with increased transforming growth factor α production. Cancer Res 61:3314-3320. (Pubitemid 32695019)
35. Davis JW Jr, Burdick AD, Lauer FT, Burchiel SW. (2003). Te aryl hydrocarbon receptor antagonist, 3′methoxy-4′nitrofavone, attenuates 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent regulation of growth factor signaling and apoptosis in the MCF-10A cell line. Toxicol Appl Pharmacol 188:42-49. (Pubitemid 36369388)
36. Dearstyne EA, Kerkvliet NI. (2002). Mechanism of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD)-induced decrease in anti-CD3-activated CD4+ T cells: Te roles of apoptosis, Fas and TNF. Toxicology 170:139-151. (Pubitemid 34031872)
37. De Herr C, Verlann AP, Penninks AH, Vos JG, Schuurman HJ, Van Loveren H. (1994). Time course of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced thymic atrophy in the Wistar rat. Toxicol Appl Pharmacol 128:97-104. (Pubitemid 24289136)
38. Denison MS, Nagy SR. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43:309-334. (Pubitemid 37372644)
39. de Torres C, Munell F, Ferrer I, Reventos J, Macaya A. (1997). Identifcation of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal brain. Neurosci Lett 230:1-4. (Pubitemid 27308517)
40. DeVito M J, Birnbaum L S (1996). Te use of body burdens vs. daily dose in comparisons of endo- and exodioxins and in assessing human health risks. Organohal Comp 29:424-429.
41. De Waal EJ, Schuurman H-J, Loeber JG, van Loveren H, Vos JG. (1992). Alterations in the cortical thymic epithelium of rats after in vivo exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): An (immuno)histological study. Toxicol Appl Pharmacol 115:80-88.
42. DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Omiecinski CJ, Perdew GH. (2010). Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of infammatory signaling. Toxicol Sci 115: 89-97.
43. Doi H, Baba T, Tohyama C, Nohara K. (2003). Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8- tetrachlorodibenhzo-p-dioxin. Chemosphere 52:655-662. (Pubitemid 36693171)
44. Dong W, Teraoka H, Kondo S, Hiraga T. (2001). 2,3,7,8-Tetrachlorodibenzo- p-dioxin induces apoptosis in the dorsal midbrain of zebrafsh embryos by activation of arylhydrocarbon receptor. Neurosci Lett 303:169-172. (Pubitemid 32373282)
45. Ekert PG, Vaux DL. (1997). Apoptosis and the immune system. Br Med Bull 53:591-603. (Pubitemid 27397312)
46. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825. (Pubitemid 23346378)
47. Elizondo G, Fernandez-Salguero P, Sheikh MS, Kim G-Y, Fornace AJ, Lee KS, Gonzalez FJ. (2000). Altered cell cycle control at the G2/M phases in aryl hydrocarbon receptor-null embryo fbroblast. Mol Pharmacol 57:1056-1063. (Pubitemid 30253392)
48. Elmore S. (2007). Apoptosis: A review of programmed cell death. Toxicol Pathol 35:495-516. (Pubitemid 46911891)
49. Enan E, Matsumura F. (1996). Identifcation of c-src as the integral component of the Ah receptor complex, trasnducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol 52:1599-612. (Pubitemid 26375466)
50. Enan E, El-Sabeawy F, Scott M, Overstreet J, Lasley B. (1998). Alterations in the growth factor signaling transduction pathways and modulators of the cell cycle in endocervical cells from macaques exposed to TCDD. Toxicol Appl Pharmacol 151:283-293. (Pubitemid 128421792)
51. Erhardt H, Häcker S, Wittmann S, Maurer M, Borkhardt A, Toloczko A, Debatin K-M, Fulda S, Jeremias I. (2008). Cytooxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. Oncogene 27:783-793. (Pubitemid 351186307)
52. Esser C. (2009). Te immune phenotype of AhR null mouse mutants: Not a simple mirror of xenobiotic over-activation. Biochem Pharmacol 77:597-607.
53. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SST, Kimura S, Nebert DW, Rudikof S, Ward JM, Gonzalez FJ. (1995). Immune system impairment and hepatic fbrosis in mice lacking the dioxin-binding Ah receptor. Science 268:722-726.
54. Fischer U, Jänicke RU, Schulze-Osthof. (2003). Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Difer 10:76-100. (Pubitemid 36511834)
55. Fisher MT, Nagarkatti M, Nagarkatti PS. (2004). Combined screening of thymocytes using apoptosis-specifc cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity. Toxicol Sci 78:116-124. (Pubitemid 38351430)
56. Fisher MT, Nagarkatti M, Nagarkatti PS. (2005). Aryl hydrocarbon receptor-dependent induction of loss of mitochondrial membrane potential in epididydimal spermatozoa by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Lett 157:99-107.
57. Fisher MT, Nagarkatti M, Nagarkatti PS. (2005). 2,3,7,8- Tetrachlorodibenzo-p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery. Mol Pharmacol 67:327-335. (Pubitemid 40069994)
58. Fletcher N, Wahlström D, Lundberg R, Nilsson CB, Nilsson KC, Stockling K, Hellmold H, Hakansson H. (2005). 2,3,7,8-Tetrachlorodibenzo-p- dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: A microarray study. Toxicol Appl Pharmacol 207:1-24. (Pubitemid 41073756)
59. Fogal V, Hsieh J-K, Royer C, Zhong S, Lu X. (2005). Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at ser315. EMBO J 24:2768-2782. (Pubitemid 41170026)
60. Friedlander RM. (2003). Apoptosis and caspases in neurodegenerative diseases. New Engl J Med 348:1365-1375. (Pubitemid 36384105)
61. Friedman JS, Lowe SW. (2003). Control of apoptosis by p53. Oncogene 22:9030-9040. (Pubitemid 38121703)
62. Frueh FW, Hayashibara KC, Brown PO, Whitlock JP Jr. (2001). Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression. Toxicol Lett 122:189-203. (Pubitemid 32727282)
63. Fujii-Kuriyama Y, Kawajiri K. (2010). Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc Jpn Acad Ser B Phys Biol Sci 86:40-53.
64. Funatake CJ, Dearstyne EA, Steppan LB, Shepherd DM, Spanjaard ES, Marshak-Rothstein A, Kerkvliet NI. (2004). Early consequences of 2,3,7,8-terachlorodibenzo-p-dioxin exposure on the activation and survival of antigen-specifc T cells. Toxicol Sci 82:129-142. (Pubitemid 39485328)
65. Funutake CJ, Marshall NB, Steppan LB, Mourich DV, Kerkvliet NI. (2005). Cutting Edge: Activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells. J Immunol 175:4184-4188. (Pubitemid 41361950)
66. Gaido KW, Maness SC, Leonard LS, Greenlee WF. (1992). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcritpzional and post-transcriptional control. J Biol Chem 267:24591-24595.
67. Gasiewicz TA, Singh KP, Casado FL. (2010). Te aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: Implications for benzene-induced hematopoietic toxicity. Chem Biol Interact 184:246-251.
68. Gogal RM Jr, Holladay SD. (2008). Perinatal TCDD exposure and the adult onset of autoimmune disease. J Immunotoxicol 5:413-418.
69. Gonzalez FJ, Fernandez-Salguero P. (1998). Te aryl hydrocarbon receptor: Studies using AHR-null mice. Drug Metab Dispos 26:1194-1198.
70. Green DR, Reed JC. (1998). Mitochondria and apoptosis. Science 281:1309-1312. (Pubitemid 28406816)
71. Guengerich FP. (2001). Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611-650. (Pubitemid 32565712)
72. Guo L, Zhao YY, Hhao YY, Sun ZJ, Liu H, Zhang SL. (2007). Toxic efects of TCDD on osteogenesis through altering IGFBP-6 gene expression in osteoblasts. Biol Pharm Bull 30:2018-2026. (Pubitemid 350097032)
73. Häcker G. (2000). Te morphology of apoptosis. Cell Tissue Res 301:5-17.
74. Hannan D, Weinberg RA. (2000). Te hallmarks of cancer. Cell 100:57-70.
75. Hattis D, Chu M, Rahmioglu N, Goble R, Verma P, Hartman K, Kozlak M. (2009). A preliminary operational classifcation system for nonmutagenic modes of action for carcinogens. Crit Rev Toxicol 39:97-138.
76. Haupt S, Berger M, Goldberg Z, Haupt Y. (2003). Apoptosis-Te p53network. J Cell Sci 116:4077-4085.
77. Heimler I, Trewin AL, Chafn CL, Rawlins RG, Hutz RJ. (1998a). Modulation of ovarian follicle maturation and efects on apoptotic cell death in Holtzman rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in utero and lactationally. Reprod Toxicol 12:69-73. (Pubitemid 29108287)
78. Heimler I, Rawlins RG, Owen H, Hutz RJ. (1998b). Dioxin pertubates, in a dose- and time-dependent fashion, steroid sectretion, and induces apoptosis of human luteinized granulosa cells. Endocrinology 139:4373-4379. (Pubitemid 28513727)
79. Henry EC, Welle SL, Gasiewicz TA. (2010). TCDD and a putative endogenous AhR ligand, ITE, elicit the same immediate changes in gene expression in mouse lung fbroblasts. Toxicol Sci 114:90-100.
80. Holder JW, Menzel HM. (1989). Analysis of 2,3,7,8-TCDD tumor promotion activity and its relationship to cancer. Chemosphere 19:861-868.
81. Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, Fornace AJ Jr. (1993). Analysis of the mammalian gadd45 gene and its response to DNA damage. J Biol Chem 268:24385-24393. (Pubitemid 23335431)
82. Holsapple MP, Morris DL, Wood SC, Snyder NK. (1991). 2,3,7,8- Tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: Possible mechanisms. Annu Rev Pharmacol Toxicol 31:73-100. (Pubitemid 21903842)
83. Hossain A, Tsuchiya S, Minegishi M, Osada M, Ikawa S, Tezuka F-a, Kaji M, Konno T, Watanabe M, Kikuchi H. (1998). Te Ah receptor is not involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in human leukemic T cell lines. J Biol Chem 273:19853-19858. (Pubitemid 28367050)
84. Huang P, Tofghi R, Emgard M, Ceccatelli S. (2005). Cell death induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) in AtT-20 pituitary cells. Toxicology 207:391-399. (Pubitemid 40138936)
85. International Agency for Research on Cancer. (1997). Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 69. Lyon: International Agency for Research on Cancer.
86. Inouye K, Shinkyo R, Takita T, Ohta M, Sakaki T. (2002). Metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) by human cytochrome P450-dependent monooxygenase systems. J Agric Food Chem 50:5496-5502. (Pubitemid 35001317)
87. Ishimaru N, Takagi A, Kohashi M, Yamada A, Arakaki R, Kanno J, Hayashi Y. (2009). Neonatal exposure to low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin causes autoimmunity due to the disruption of T cell tomerance. J Immunol 182:6576-6586.
88. Ito T, Tsukumo S, Suzuki N, Motohashi H, Yamamoto M, Fujii-Kuriyama Y, Mimura J, Lin T-M, Peterson RE, Toyama C, Nohara K. (2004). A constitutively active arylhydrocarbon receptor induces growth inhibition of Jurkat T cells through chnages in the expression of genes related to apoptosis and cell cycle arrest. J Biol Chem 279 :25204-25210. (Pubitemid 38756771)
89. Jana S, Paliwal J. (2007). Molecular mechanisms of cytochrome p450 induction: Potential for drug-drug interactions. Curr Protein Pept Sci 8:619-628. (Pubitemid 351266993)
90. Jennen DGJ, Magkoufopoulou C, Ketelsleger HB, van Herwijnen MHM, Kleinjans JCS, van Delft JHM. (2010). Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identifcation. Toxicol Sci 115:66-79.
91. Jennings AM, Wild G, Ward JD, Ward AM. (1988). Immunological abnormalities 17 years after accidental exposure to 2,3,7,8-tetrachlorodibenzo- p-dioxin. Br J Ind Med 45:701-704.
92. Jin Z, El-Deiry WS. (2005). Overview of cell death signaling pathways. Cancer Biol Ter 4:139-163. (Pubitemid 41351311)
93. Jönsson ME, Franks DG, Woodin BR, Jenny MJ, Garrick RA, Behrendt L, Hahn ME, Stegeman JJ. (2009). Te tryptophan photoproduct 6-formylindolo[3,2-b] carbazole (FICZ) binds multiple AhRs and induces multiple CYP1 genes via AhR2 in zebrafsh. Chem Biol Interact 181:447-454.
94. Kamath AB, Xu H, Nagarkatti PS, Nagarkatti M. (1997). Evidence fort he induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol Appl Pharmacol 142:367-377. (Pubitemid 28381028)
95. Kamath AB, Nagarkatti PS, Nagarkatti M. (1998). Characterization of phenytipic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocytes in vivo and its efect on apoptosis. Toxicol Appl Pharmacol 150:117-124. (Pubitemid 28288426)
96. Kamath AB, Camacho I, Nagarkatti PS, Nagarkatti M. (1999). Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity: Increased resistance of thymocytes from Fas-defcient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity. Toxicol Appl Pharmacol 160:141-155. (Pubitemid 29498398)
97. Kawajiri K, Fujii-Kuriyama Y. (2007). Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor. Arch Biochem Biophys 464:207-212. (Pubitemid 47210921)
98. Kelly KJ, Sandoval RM, Dunn KW, Molitoris BA, Dagher PC. (2003). A novel method to determine specifty and sensitivity of the TUNEL reaction in the quantitation of apoptosis. Am J Physiol Cell Physiol 284:C1309-1318. (Pubitemid 36457412)
99. Kerkvliet NI. (1995). Immunological efects of chlorinated dibenzo-p-dioxins. Environ Health Perpect 103(Suppl 9):47-53.
100. Kerkvliet NI. (2002). Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2:277-291. (Pubitemid 34075417)
101. Kerkvliet NI. (2009). AHR-mediated immunomodulation: Te role of altered gene transcription. Biochem Pharmacol 77:746-760.
102. Kerr JF, Wyllie AH, Currie AR. (1972). Apoptosis: Abasic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
103. Kho PS, Wang Z, Zhuang L, Li Y, Chew J-L, Ng H-H, Liu ET, Yu Q. (2004). p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J Biol Chem 279:21183-21192. (Pubitemid 38656522)
104. Kikuchi H, Shibazaki M, Ahmed S, Baba T. (2001). Method for evaluation of immunotoxicity of dioxin compounds using human T-lymphoblastic cell line, L-MAT. Chemosphere 43:815-818. (Pubitemid 32405534)
105. Kishimoto H, Surh CD, Sprent J. (1995). Upregulation of surface markers on dying thymocytes. J Exp Med 181:649-655.
106. Knerr S, Schrenk D. (2006). Carcinogenicityof 2,3,7,8-tetrachlorodibenzo- p-dioxin in experimental models. Mol Nutr Food Res 50:897-907.
107. Kobayashi D, Ahmed S, Ishida M, Kasai S, Kikuchi H. (2009). Calcium/ calmodulin signaling elicits release of cytochrome c during 2,3,7,8- tetrachlorodibenzo-p-dioxin-induced apoptosis in the human lymphoblastic T-cell line, L-MAT. Toxicology 258:25-32.
108. Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CN, Barnard SD, Hummel RA, Humiston CG. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8- tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 46:279-303. (Pubitemid 9077600)
109. Kogevinas M, Becher H, Benn T, Bertazzi PA, Bofetta P, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Fingerhut M, Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M, Pearce N, Saracci R. (1997). Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. Am J Epidemiol 145:1061-1075.
110. Kwon M-J, Jeong K-S, Choi EJ, Lee BH. (2003). 2,3,7,8-Tetrachlorodibenzo- p-dioxin (TCDD)-induced activation of mitogen-activated protein kinase signaling pathway in Jurkat T cells. Pharmacol Toxicol 93:186-190. (Pubitemid 37346658)
111. Lahvis GP, Bradfeld CA. (1998). Ahr null alleles: Distinctive or diferent. Biochem Pharmacol 56:781-787. (Pubitemid 28458971)
112. Lai Z-W, Fiore NC, Hahn PJ, Gasiewicz TA, Silverstone AE. (2000). Diferential efects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocyte diferentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol Appl Pharmacol 168:15-24.
113. Lang DS, Becker S, Devlin RB, Koren HS. (1996). 2,3,7,8-TCDD induces cytochrome P450 enzyme activity but not proliferation or phenotypical changes in human peripheral blood lymphocytes. Toxicol Lett 88:317-325. (Pubitemid 26361286)
114. Lawrence BP, Leid M, Kerkvliet NI. (1996). Distribution and behaviour of the Ah receptor in murine T lymphocytes. Toxicol Appl Pharmacol 138:275-284. (Pubitemid 26227599)
115. Leu JI, George DL. (2007). Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis and antagonizes the proapoptotic actions of p53 at mitochondria. Genes Dev 21:3095-3109. (Pubitemid 350223527)
116. Lin T-M, Ko K, Moore RW, Buchanan DL, Cooke PS, Peterson RE. (2001). Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed male mice. J Toxicol Environ Health A 64:327-342. (Pubitemid 32989446)
117. Loertscher JA, Sadek CS, Allen-Hofmann BL. (2001a). Treatment of normal human keratinocytes with 2,3,7,8-tetrachlorodibenzo-p-dioxin causes a reduction in cell number, but no increase in apoptosis. Toxicol Appl Pharmacol 175:114-120. (Pubitemid 32848502)
118. Loertscher JA, Sattler CA, Allen-Hofmann BL. (2001b). 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the diferentiation pattern of human keratinocytes in organotypic culture. Toxicol Appl Pharmacol 175:121-129. (Pubitemid 32848503)
119. Laiosa MD, Wyman A, Murante FG, Fiore NC, Staples JE, Gasiewicz TA, Silverstone AE. (2003). Cell proliferation arrest within intrathymic lymphocyte progenitor cells causes thymic atrophy mediated by the aryl hydrocarbon receptor. J Immunol 171:4582-4591. (Pubitemid 37310574)
120. Lowe SW, Lin AW. (2000). Apoptosis in cancer. Carcinogenesis 21:485-495. (Pubitemid 30137934)
121. Mahoney JA, Rosen A. (2005). Apoptosis and autoimmunity. Curr Opin Immunol 17:585-588.
122. Manz A, Flesch-Janys D, Waltsgott H, Berger J, Nagel S, Dwyer JH. (1991). Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet 388:959-964.
123. Marchand A, Tomkiewicz C, Marchandeau J-P, Boitier E, Barouki R, Garlatti M. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces insulin-like growth factor binding protein-1 gene expression and counteracts the negative efect of insulin. Mol Pharmacol 67:444-452. (Pubitemid 40216737)
124. Marlowe JL, Fan Y, Chang X, Peng L, Knudsen ES, Xia Y, Puga A. (2008). Te aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell 19:3263-3271.
125. Martin SJ, Green DR. (1995). Apoptosis and cancer: Te failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 18:137-153.
126. Mathew LK, Simonrich MT, Tanguay RL. (2009). AHR-dependent misregulation of Wnt signaling disrupts tissue regeneration. Biochem Pharmacol 77:498-507.
127. Matsumura F. (2009). Te signifcance of the nongenomic pathway in mediating infammatory signaling of the dioxin-activated Ah receptor to cause toxic efects. Biochem Pharmacol 77:608-626.
128. Matthews M, Heimler I, Fahy M, Radwanska E, Hutz R, Trewin A, Rawlins R. (2001). Efects of dioxin, an environmental pollutant, on mouse blastocyst development and apoptosis. Fertil Steril 75:1159-1162. (Pubitemid 32522614)
129. Mayer B, Oberbauer R. (2003). Mitochondrial regulation of apoptosis. News Physiol Sci 18:89-94. (Pubitemid 36782796)
130. McGregor DB, Partensky C, Wilbourn J, Rice JM. (1998). An IARC evaluation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans as risk factors in human carcinogenesis. Environ Health Perspect 106(Suppl 2):755-760. (Pubitemid 28256787)
131. McConkey DJ, Hartzell P, Duddy SK, Hakansson H, Orrenius S. (1988). 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation. Science 242:256-259.
132. Mellor H, Parker PJ. (1998). Te extended protein kinase C superfamily. Biochem J 332:281-292.
133. Michalek JE, Ketchum NS, Check IJ. (1999). Serum dioxin and immunologic response in veterans of operation ranch hand. Am J Epidemiol 149:1038-1046. (Pubitemid 29246869)
134. Minami K, Nakajima M, Fujiki Y, Katoh M, Gonzales FJ, Yokoi T. (2008). Regulation of insulin-like growth factor binding protein-1 and lipoprotein lipase by the aryl hydrocarbon receptor. J Toxicol Sci 33:405-413.
135. Moll UM, Petrenko O. (2003). Te MDM2-p53 interaction. Mol Cancer Res 1:1001-1008.
136. Morris DL, Snyder NK, Gokani V, Blair RE, Holsapple MP. (1992). Enhanced suppression of humoral immunity in DBA/2 mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Appl Pharmacol 112:128-132.
137. Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M, Krammer PH. (1998). p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 188:2033-2045. (Pubitemid 28562520)
138. Mustafa A, Holladay SD, Witonsky S, Zimmerman K, Reilly CM, Sponenberg DP, Weinstein DA, Karpuzoglu E, Gogal RM Jr. (2009). Gestational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin disrupts B-cell lymphopoiesis and exacerbates autoimmune disease in 24-week-old SNF1 mice. Toxicol Sci 112:133-143.
139. Nagai H, Kubo M, Abe R, Yamamoto M, Nohara K. (2006). Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway. Int Immunopharmacol 6:279-286. (Pubitemid 43052825)
140. Neal RA. (1985). Mechanisms of the biological efects of PCBs, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans in experimental animals. Environ Health Perspect 60:41-46. (Pubitemid 15038883)
141. Nguyen LP, Hsu EL, Chowdhury G, Dostalek M, Guengerich FP, Bradfeld CA. (2009). D-amino acid oxidase generates agonists of the aryl hydrocarbon receptor from d-tryptophan. Chem Res Toxicol 22:1897-1904.
142. Nikolova M, Lelievre J-D, Carriere M, Bensussan A, Levy Y. (2009). Regulatory T cells diferentially modulate maturation and apoptosis of human CD8+ T-cell subsets. Blood 113:4556-4565.
143. Nohara K, Pan X, Tsukumo S-i, Hida A, Ito T, Nagai H, Inouye K, Motohashi H, Yamamoto M, Fujii-Kuriyama Y, Tohyama C. (2005). Constitutively active aryl hydrocarbon receptor expressed specifcally in T-lineade cells causes thymus involution and suppresses the immunization-induced increase in splenocytes. J Immunol 174:2770-2777. (Pubitemid 40279693)
144. North CM, Crawford RB, Lu H, Kaminski NE. (2009). Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response. Toxicol Sci 112:123-132.
145. Oesch-Bartlomowicz B, Oesch F. (2009). Role of cAMP in mediating AHR signaling. Biochem Pharmacol 77:627-641.
146. Ohtake F, Fujii-Kuriyama Y, Kato S. (2009). AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochem Pharmacol 77:474-484.
147. Olson JR, Holscher MA, Neal RA. (1980). Toxicity of 2,3,7,8- tetrachlorodibenzo-p-dioxin in the Golden Syrian hamster. Toxicol Appl Pharmacol 55:67-78. (Pubitemid 10036692)
148. Pääjärvi G, Viluksela M, Pohjanvirta R, Stenius U, Högberg J. (2005). TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents. Carcinogenesis 26:201-208. (Pubitemid 40214336)
149. Pande K, Moran SM, Bradfeld CA. (2005). Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines. Mol Pharmacol 67:1393-1398. (Pubitemid 40594137)
150. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. (2007). CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of efector CD4+ T cells. Nat Immunol 8:1353-1362. (Pubitemid 350131172)
151. Panteleyev AA, Bickers DR. (2006). Dioxin-induced chloracne- Reconstituting the cellular and molecular mechanisms of a classic environmental disease. Exp Dermatol 15:705-730. (Pubitemid 44145241)
152. Park J-H, Lee S-W, Kim I-T, Shin B-S, Cheong S-W, Cho U-H, Huh M-J, Oh G-S. (2001). TCDD-up-regulation of IGFBP-6 and IL-5R alpha subunit genes in vivo and in vitro. Mol Cells 12:372-379. (Pubitemid 33666019)
153. Park J-H, Hahn E-J, Kong J-H, Cho H-J, Yoon C-S, Cheong S-W, Oh G-S, Youn H-J. (2003). TCDD-induced apoptosis in EL-4 cells defcient of the aryl hydrocarbon receptor and down-regulation of IGFBP-6 prevented the apoptotic cell death. Toxicol Lett 145:55-68. (Pubitemid 38366129)
154. Park K-T, Mitchell KA, Huang G, Elferink CJ. (2005). Te aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis. Mol Pharmacol 67:612-622. (Pubitemid 40365308)
155. Park S, Matsumura F. (2006). Characterization of anti-apoptotic action of TCDD as a defensive cellular stress response reaction against the cell damaging action of ultra-violet irradiation in an immortalized normal human mammary epithelial cell line, MCF10A. Toxicology 217:139-146. (Pubitemid 41773829)
156. Pesatori AC, Consonni D, Rubagotti M, Grillo P, Bertazzi PA. (2009). Cancer incidence in the population exposed to dioxin after the "Seveso accident": Twenty years of follow-up. Environ Health 8:39.
157. Peterson RE, Teobald HM, Kimmel GL. (1993). Developmental and reproductive toxicity of dioxins and related compounds: Cross-species comparisons. Crit Rev Toxicol 23:283-335. (Pubitemid 23274471)
158. Ping-Yuan L, Hung-Jen L, Meng-Jiun L, Feng-Ling Y, Hsue-Yin H, Jeng-Woei L, Wen-Ling S. (2006). Avian reovirus activates a novel proapoptotic signal linking src to p53. Apoptosis 11:2179-2193. (Pubitemid 44885394)
159. Plant N, Aouabdi S. (2009). Nuclear receptors: Te controlling force in drug metabolism of the liver? Xenobiotica 39:597-605.
160. Pohjanvirta R, Viluksela M, Tuomisto JT, Unkila M, Karasinska J, Franc MA, Holowenko M, Giannone JV, Harper PA, Tuomisto J, Okey AB. (1999). Physicochemical diferences in the AH receptor of the most TCDD-susceptible and the most TCDD-resistant rat strains. Toxicol Appl Pharmacol 155:82-95. (Pubitemid 29102764)
161. Pohler E, Craig AL, Cotton J, Lawrie L, Dillon J F, Ross P, Kernohan N, Hupp TR. (2004). Te Barrett′s antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol Cell Proteom 3:534-547. (Pubitemid 38878513)
162. Polager S, Gisberg D. (2009). p53 and E2f: Partners in life and death. Nat Rev Cancer 9:738-748.
163. Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG. (2004). E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res 2:203-214. (Pubitemid 39031081)
164. Prell RA, Dearstyne E, Steppan LG, Vella AT, Kerkvliet NI. (2000). CTL hyporesponsiveness induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Role of cytokines and apoptosis. Toxicol Appl Pharmacol 166:214-221. (Pubitemid 30640631)
165. Pryputniewicz SJ, Nagarkatti M, Nagarkatti PS. (1998). Diferential induction of apoptosis in activated and resting T cells by 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) and its repercussion on T cell responsiveness. Toxicology 129:211-226. (Pubitemid 29023149)
166. Ray SS, Swanson HI. (2004). Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a. J Biol Chem 279:27187-27193. (Pubitemid 38812555)
167. Reyes-Hernandez OD, Mejia-Garcia A, Sanchez-Ocampo EM, Cabanas-Cortes MA, Ramirez P, Chavez-Gonzalez L, Gonzalez FJ, Elizondo G. (2010). Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: Implications for p53 ubiquitination. Biochem Pharmacol 80:932-940.
168. Robertson JD, Orrenius S. (2000). Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 30:609-627.
169. Romashkova JA, Makarov SS. (1999). NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90.
170. Ruby CE, Funatake CJ, Kerkvliet NI. (2005). 2,3,7,8-Tetrachlorodibenzo-p- dioxin directly enhances the maturation and apoptosis of dendritic cells in vitro. J Immuntoxicol 1:159-166.
171. Rushmore TH, Kong AN. (2002). Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 3:481-490. (Pubitemid 34987481)
172. Safe S (1997). Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds. Teratog Carcinog Mutagen 17:285-304. (Pubitemid 28080831)
173. Saito T, Watanabe N. (1998). Positive and negative thymocyte selection. Crit Rev Immunol 18:359-370. (Pubitemid 28364151)
174. Sakamoto MK, Mima S, Tanimura T. (1995). A morphological study of liver lesions in Xenopus larvae exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) with special reference to apoptosis of hepatocytes. J Environ Pathol Toxicol Oncol 14:69-82. (Pubitemid 26097048)
175. Sakamoto MK, Mima S, Takahashi KP, Tanimura T. (1997). Apoptotic cell death of erythrocytes in Xenopus larvae exposed to 2,3,7,8-tetrachlorodibenzo-p- dioxin. Toxicol Pathol 25:398-402. (Pubitemid 27364940)
176. Sanchez-Martin FJ, Fernandez-Salguero PM, Merino JM. (2010). 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces apoptosis in neural growth factor (NGF)-diferentiated pheochromocytoma PC12 cells. Neurotoxicology 31:267-276.
177. Santostefano M, Merchant M, Arellano L, Morrison V, Denison MS, Safe S. (1993). Alpha-naphthofavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation. Mol Pharmacol 43:200-206. (Pubitemid 23055063)
178. Savil J. (1997). Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 53:491-508.
179. Schmidt JV, Su GH-T, Reddy JK, Simon MC, Bradfeld CA. (1996). Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 93:6731-6736. (Pubitemid 26230378)
180. Schreck I, Chudziak D, Schneider S, Seidel A, Platt KL, Oesch F, Weiss C. (2009). Infuence of aryl hydrocarbon- (Ah) receptor and genotoxins on DNA repair gene expression and cell survival of mouse hepatoma cells. Toxicology 259:91-96.
181. Schrenk D, Müller M, Merlino G, Torgeirsson SS. (1997). Interactions of TCDD with signal transduction and neoplastic development in c-myc transgenic and TGF-α transgenic mice. Arch Toxicol Suppl 19:367-375.
182. Schrenk D, Kunz S, Schmitz H-J. (2004). Modulation of caspase-3-activation by liver tumor promoters in primary rat hepatocytes. Toxicol Appl Pharmacol 197:374.
183. Schroeder JC, Dinatale BC, Murray IA, Flaveny CA, Liu Q, Laurenzana EM, Lin JM, Strom SC, Omiecinski CJ, Armin S, Perdew GH. (2010). Te uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry 49:393-400.
184. Schroy JM, Hileman FD, Chang SC. (1985). Physical/chemical properties of 2,3,7,8-TCDD. Chemosphere 14:877-880.
185. Schulte-Hermann R, Bursch W, Grasl-Kraupp B. (1995). Active cell death (apoptosis) in liver biology and deisease. Prog Liver Dis 13:1-35.
186. Schulze-Bergkamen H, Krammer PH. (2004). Apoptosis in cancer- Implications for therapy. Semin Oncol 31:90-119.
187. Schwarz M, Buchmann A, Stinchcombe S, Kalkuhl A, Bock K-W. (2000). Ah receptor ligands and tumor promotion: Survival of neoplastic cells. Toxicol Lett 112-113:69-77. (Pubitemid 30138106)
188. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS. (1999). Selection of the T cell repertoire. Annu Rev Immunol 17:829-874. (Pubitemid 29241141)
189. Seefeld MD, Corbett SW, Keesey RE, Peterson RE. (1984). Characterizyteion of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p- dioxin. Toxicol Appl Pharmacol 73:311-322. (Pubitemid 14135566)
190. Seifert A, Taubert H, Hombach-Klonisch S, Fischer B, Navarrete Santos A. (2009). TCDD mediates inhibition of p53 and activation of ERalpha signaling in MCF-7 cells at moderate hypoxic conditions. Int J Oncol 35:417-424.
191. Shi Y. (2002). Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9:459-470. (Pubitemid 34273778)
192. Simon T, Aylward LL, Kirman CR, Rowlands JC, Budinsky RA. (2009). Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p) dioxin using linear and nonlinear dose-response modeling and toxicokinetics. Toxicol Sci 112:490-506.
193. Singh NP, Nagarkatti M, Nagarkatti P. (2008). Primary peripheral T cells become susceptible to 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in vitro upon activation and the presence of dentritic cells. Mol Pharmacol 73:1722-1735. (Pubitemid 351724360)
194. Speidel D. (2009). Transcription-independent p53 apoptosis: An alternative route to death. Trends Cell Biol 20:14-24.
195. Stanley LA, Horsburgh BC, Ross J, Scheer N,Wolf CR. (2009). Drug transporters: Gatekeepers controlling access of xenobiotics to the cellular interior. Drug Metab Rev 41:27-65.
196. Staples JE, Murante FG, Fiore NC, Gasiewicz TA, Silverstone AE. (1998). Tymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. J Immunol 160:3844-3854. (Pubitemid 28176089)
197. Stephen FD, Drahushuk AT, Olson JR. (1997). Cytochome P450 1A1 induction in rat lymphoid tissues following in vivo and in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin requires protein kinase C. Toxicology 124:39-51. (Pubitemid 27483495)
198. Stevens EA, Mezrich JD, Bradfeld CA. (2009). Te aryl hydrocarbon receptor: A perspective on potential roles in the immune system. Immunology 127:299-311.
199. Stinchcombe S, Buchmann A, Bock KW, Schwarz M. (1995). Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. Carcinogenesis 16:1271-1275.
200. Strange R, Metcalfe T, Tackray L, Dang M. (2001). Apoptosis in normal and neoplastc mammary gland development. Microsc Res Tech 52:171-181. (Pubitemid 32107805)
201. Strauss L, Bergmann C, Whiteside TL. (2009). Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis. J Immunol 182:1469-1480.
202. Sun YV, Boverhof DR, Burgoon LD, Fielden MR, Zacharewski TR. (2004). Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res 32:4512-4523. (Pubitemid 39317729)
203. Suskind RR. (1985). Chloracne, "the hallmark of dioxin intoxication". Scand J Work Environ Health 11:165-171.
204. Swedenborg E, Pongratz I. (2010). AhR and ARNT modulate ER signaling. Toxicology 268:132-138.
205. Tian Y. (2009). Ah receptor and NF-kappaB interplay on the stage of epigenome. Biochem Pharmacol 77:670-680.
206. Timmer JC, Salvesen GS. (2006). Caspase substrates. Cell Death Difer 14:66-72. (Pubitemid 44911895)
207. Tomita S, Jiang H-B, Ueno T, Takagi S, Tohi K, Maekawa S-i, Miyatake A, Furukawa A, Gonzalez FJ, Takeda J, Ichikawa Y, Takahama Y. (2003). T cell-specifc disruption of arylhydrocarbon receptor nuclear translocator (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution. J Immunol 171:4113-4120. (Pubitemid 37238687)
208. Toomey BH, Bello S, Hahn ME, Cantrell S, Wright P, Tillitt DE, Di Guilio RT. (2001). 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces apoptotic cell death and cytochrome P4501A expression in developing Fundulus heteroclitus embryos. Aquat Toxicol 53:127-138. (Pubitemid 32318545)
209. Tu Y, Wu W, wu T, Cao Z, Wilkins R, Toh B-H, Cooper ME, Chai Z. (2007). Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21Waf1/Cip1 by activating p53 and MEK/ERK1/2 MAPK pathways. J Biol Chem 282:11722-11731. (Pubitemid 47100724)
210. US Environmental Protection Agency. (1994). Health assessment document for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCPD) and related compounds [external review draft] [3 volumes]. Washington, DC: Ofce of Research and Development, National Center for Environmental Assessment Ofce of Research and Development, US Environmental Protection Agency.
211. US Environmental Protection Agency. (2006). An Inventory of Sources and Environmental Releases of Dioxin-Like Compounds in the United States for the Years 1987, 1995, and 2000. Washington, DC: National Center for Environmental Assessment Ofce of Research and Development US Environmental Protection Agency.
212. US National Toxicology Program. (2005). Report on Carcinogens, Eleventh Edition. US Research Triangle Park, NC: Department of Health and Human Services, Public Health Service, National Toxicology Program.
213. van den Berg M, de Jongh J, Poiger H, Olson J R. (1994). Te toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. Crit Rev Toxicol 24: 1-74. (Pubitemid 24122407)
214. van den Berg M, Birnbaum L, Bosveld ATC, Brunström B, Cook P, Feeley M, Giesy JP, Hanberg A, Hasegawa R, Kennedy SW, Kubiak T, Larsen JC, van Leeuwen FXR, Liem AKD, Nolt C, Peterson RE, Poellinger L, Safe S, Schrenk D, Tillitt D, Tysklind M, Younes M, Waern F, Zacharewski T. (1998). Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 106:775-792. (Pubitemid 29073822)
215. van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansso H, Hanberg A, Haws L, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walker N, Peterson RE. (2006). Te 2005 World Health Organization re-evaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93:223.241.
216. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld J-C, Stockinger B. (2008). Te aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453:106-109. (Pubitemid 351630329)
217. Venet F, Pachot A, Debard A-L, Bohe J, Bienvenu J, Lepape A, Powell WS, Monneret G. (2006). Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 177:6540-6547. (Pubitemid 44628873)
218. Vercoulen Y, Wehrens EJ, van Teijlingen NH, de Jager W, Beekman JM, Brakken BJ. (2009). Human regulatory T cell suppressive function is independent of apoptosis induction in activated efector T cells. PLoS ONE 4:e7183.
219. Vogel CFA, Li W, Sciullo E, Newman J, Hammock B, Reader JR, Tuscano J, Matsumura F. (2007). Pathogenesis of aryl hydracarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. Am J Pathol 171:1538-1548. (Pubitemid 350158315)
220. Vos JG, Moore JA, Zinkl JG. (1973). Efect of 2,3,7,8-tetrachlorodibenzo- p-dioxin on the immune system of laboratory animals. Environ Health Perspect 5:149-162.
221. Walker CH, Tyler C. (2008). Organic Pollutants: An Ecotoxicological Perspective. 2nd ed. Boca Raton, FL: CRC Press.
222. Watson CJ. (2006). Key stages in mammary gland development. Involution: Apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res 8:203.
223. Whyte J, Bergin O, Bianchi A, McNally S, Martin F. (2009). Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammalian gland development. Breast Cancer Res 11:209.
224. Wong PS, Li W, Vogel CF, Matsumura F. (2009). Characterization of MCF mammary epithelial cells overexpressing the arylhydrocarbon receptor (AhR). BMC Cancer 9:234.
225. Wörner W, Schrenk D. (1996). Infuence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofuorene, ultraviolet light, or transforming growth factor β1. Cancer Res 56:1272-1278. (Pubitemid 26080969)
226. Wörner W, Schrenk D. (1998). 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses apoptosis and leads to hyperphosphorylation of p53 in rat hepatocytes. Environ Toxicol Pharmacol 6:239-247. (Pubitemid 29070815)
227. Wyllie AH. Apoptosis and carcinogenesis. Eur J Cell Biol 73:189-197.
228. Xu C, Li CY, Kong AN. (2005). Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249-268. (Pubitemid 44698742)
229. Yoshizawa K, Marsh T, Foley JF, Cai B, Peddada S, Walker NJ, Nyska A. (2005). Mechanisms of exocrine pancreatic toxicity induced by oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Harlan Sprague-Dawley rats. Toxicol Sci 85:594-606. (Pubitemid 40614288)
230. Yun J, Chae H-D, Choy HE, Chung J, Yoo H-S, Han M-H, Shin DY. (1999). p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J Biol Chem 274:29677-29682.
231. Zeytun A, McKallip RJ, Fisher M, Camacho I, Nagarkatti M, Nagarkatti PS. (2002). Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profle in vivo using pathway-specifc cDNA arrays. Toxicology 178:241-260. (Pubitemid 34880022)
232. Zordoky BN, El-Kadi AO. (2009). Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr Drug Metab 10:164-178.
233. Zordoky BN, El-Kadi AO. (2009). Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr Drug Metab 10:164-178.